All articles by Phillip Broadwith – Page 20
-
ReviewWhat a wonderful world: one man’s attempt to explain the big stuff
Don’t know much about a science book
-
BusinessLanzatech expands waste-to-chemicals range
Partnership with Evonik will see gas-guzzling microbes make polymer precursors
-
Business
Merck KGaA snaps up electronic materials specialist
Firm looks to bolster R&D by acquiring AZ Electronic Materials
-
BusinessNike eliminates water at new Taiwanese dyeing plant
ColorDry process uses supercritical CO2 to reduce waste and cut costs
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DSM to spin out pharma unit
Firm will combine with Patheon to provide manufacturing services
-
BusinessRapid DNA sequencing cleared for the clinic
Illumina’s ‘next-generation’ MiSeqDx platform gets US approval
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
BusinessFracking risks are manageable, says UK industry body
Environmental impact of shale gas exploration should be minimal with proper oversight
-
Business
Shire will cut UK R&D to focus on rare diseases
$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
-
-
Business
Vertex to cut 370 jobs
Imminent competition drives drop in its hepatitis C drug’s performance
-
Business
BASF to move pigments production to Asia
Firm will cut 650 jobs, close UK plant and expand in China and Korea
-
Business
Counterfeit anxiety pills seized in Switzerland
1 million fake tablets were en route from China to Egypt
-
Business
Solvay expands surfactants business with Chemlogics buyout
$1.3bn deal brings firm into booming US oil and gas drilling market